ArticleJID innovations : skin science from molecules to population health2024

Treatment of Bullous Pemphigoid with Avdoralimab: Multicenter, Randomized, Open-Labeled Phase 2 Study.

Thierry Passeron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.